Although therapeutic interventions with the aim to lower UA with xanthine oxidase inhibitors may be beneficial in treating the vascular disorders associated with renal disease, debate is still ongoing whether the effect is related to lowering UA levels per se, or to reduced xanthine oxidase activity. Here, XDH is linked to kidney disorder.